Pfizer and BioNTech submit data to EMA for COVID-19 vaccine for children ages 5-11

  • Pfizer (PFE) and BioNTech (BNTX) have submitted data to the European Medicines Agency to support their COVID-19 vaccine for use in children between the ages of 5 and 11 years old.
  • Data from a phase 2/3 trial showed that a regimen of two 10-µg doses registered a similar antibody response as two 30-µg doses given to individuals 16 to 25 years old in another study.
  • The vaccine was also well tolerated in the 5-11 years old age group.
  • The same data was sent to the FDA for the companies' request to extend authorization in the U.S. for that population. An agency advisory panel will discuss that request on Oct. 26.

    For this year Pfizer 's revenue will be around 80.93 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 41.91 billion USD.

    Historical revenues and results Pfizer plus estimates 2021

    fundamenteel onderzoek

    The analysts expect for 2021 a net profit of 23.43 billion USD. According to most of the analysts the company will have a profit per share for this book year of 4.12 USD. Based on this the price/earnings-ratio is 10.4.

    Huge dividend Pfizer

    Analysts expect a dividend of 1.58 USD per share. Pfizer 's dividend yield thus equals 3.69 percent. The average dividend yield of the pharmaceutical companies equals a moderate 1.37 percent.

    Most recent target prices around 44 USD

    JP Morgan, ABN AMRO and Barclays recently provided recommendations for the stock.

    Pfizer 's market value equals around 237.19 billion . 26

    At 20.31 the stock trades 0.55 percent higher at 42.86 USD.

    Historical stock prices Pfizer

    stock graphs pfizer

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.